Mark Tarr Sells 150,000 Shares of Encompass Health (NYSE:EHC) Stock

Encompass Health Corporation (NYSE:EHC) CEO Mark Tarr sold 150,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the transaction, the chief executive officer directly owned 377,070 shares of the company’s stock, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Encompass Health Stock Down 1.1%

Shares of Encompass Health stock traded down $1.27 during trading hours on Thursday, reaching $112.16. 2,129,835 shares of the company were exchanged, compared to its average volume of 1,486,056. The firm has a market cap of $11.29 billion, a PE ratio of 20.25, a PEG ratio of 2.07 and a beta of 0.73. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.08. Encompass Health Corporation has a 1 year low of $92.53 and a 1 year high of $127.99. The stock’s fifty day moving average is $104.00 and its 200 day moving average is $114.49.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The firm had revenue of $3.09 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same period in the prior year, the firm earned $1.17 earnings per share. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, equities research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Hedge Funds Weigh In On Encompass Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Citizens National Bank Trust Department acquired a new position in Encompass Health during the 3rd quarter valued at approximately $26,000. First Horizon Corp acquired a new position in shares of Encompass Health in the 3rd quarter worth approximately $34,000. WPG Advisers LLC increased its holdings in shares of Encompass Health by 73.3% in the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after buying an additional 137 shares in the last quarter. Westside Investment Management Inc. raised its position in shares of Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after purchasing an additional 101 shares during the period. Finally, Flagship Harbor Advisors LLC acquired a new stake in Encompass Health during the 4th quarter worth about $37,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the topic of several research analyst reports. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Barclays lifted their price target on shares of Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a report on Friday, February 6th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus target price of $143.29.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.